Copertina

Molecular Mechanism of Dexmedetomidine in Alzheimer's Disease: Machine Learning Identifies RGS7 as a Key Therapeutic Targe

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Yangliang Yang, Anjun Xu, Pengcheng Xie, Jingli Yang
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2025
Soggetti:	Chemical Biology & Drug Design
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Network Pharmacology, Machine Learning, Molecular Docking, and Cell Experiments Reveal the Therapeutic Mechanism of Radix Rehmanniae Praeparata in Psoriasis In Vitro
di: Tingting Zhang, et al.
Pubblicazione: (2026)

The Therapeutic Effect and Mechanism of Vismodegib on COPD : Focusing on NETs and Macrophage Polarization
di: Ming Wu, et al.
Pubblicazione: (2026)

Old Drug, New Opportunity: Drug Repurposing in Cardiovascular Diseases
di: Xiuyi Ou, et al.
Pubblicazione: (2026)

Pharmacophore‐Based Identification and Molecular Characterization of Potent Neprilysin Inhibitors: Biochemical and Therapeutic Implications for Cardiovascular Diseases
di: Chung‐Ting Kuo, et al.
Pubblicazione: (2026)

Bioinformatic Analysis of the Protective Effects of Dexmedetomidine and Thrombopoietin Against Hypoxia/Reoxygenation‐Induced Injury in AC16 Cells
di: Cuiyan Xing, et al.
Pubblicazione: (2025)

Integrated Virtual Screening and Molecular Dynamics Simulation Study to Discover Potential Activators of γ‐Aminobutyric Acid B Receptor 1 for Therapeutic Targeting of Neurodegenerative Diseases
di: Asfiya, et al.
Pubblicazione: (2026)

The Molecular Mechanism of Resveratrol in the Treatment of Chronic Rhinosinusitis Through a Combination of Network Pharmacology and In Vitro Validation
di: Xiao Cheng, et al.
Pubblicazione: (2025)

Synthesis, Bioactivity and Molecular Modeling Studies on Benzimidazole Derivatives and Its Isosteres as Potent AChE / BChE and GSK3β Inhibitors for Alzheimer's Disease
di: Gözde Sayar, et al.
Pubblicazione: (2026)

Dexmedetomidine Inhibits Ferroptosis by Regulating the SRY‐Box Transcription Factor 9/Divalent Metal Transporter‐1 Axis to Alleviate Cerebral Ischemia/Reperfusion Injury
di: Zhen Liu, et al.
Pubblicazione: (2025)

A Comprehensive Analysis on Galantamine Based Hybrids for the Management of Alzheimer's Disease
di: Yash Pal Singh, et al.
Pubblicazione: (2024)

Imino and Thioureidic Derivatives as New Tools for Alzheimer's Disease: Preliminary Studies
di: Anna Caruso, et al.
Pubblicazione: (2025)

Brusatol Exerts Therapeutic Effects in Ulcerative Colitis by Regulating the UBE 3 A ‐ LCN 2‐Mediated Ferroptosis and Inflammation Axis
di: Xingzhuo Guan, et al.
Pubblicazione: (2025)

Prediction of Drug‐Induced Liver Injury: From Molecular Physicochemical Properties and Scaffold Architectures to Machine Learning Approaches
di: Yulong Zhao, et al.
Pubblicazione: (2024)

Therapeutic Potential of 6‐Gingerol in Glioma: Mechanistic Insights and Experimental Validation
di: Shan Miao, et al.
Pubblicazione: (2025)

Multimodal Fusion of mpMRI Radiomics, Clinical Features, and Hematological Biomarkers Enhances Machine Learning‐Based Prediction of Biochemical Recurrence in Prostate Cancer Patients
di: Yinxing Zhu, et al.
Pubblicazione: (2025)

Role of PD‐1 in Skin Cancer: Molecular Mechanism, Clinical Applications, and Resistance
di: Neha Sharma, et al.
Pubblicazione: (2024)

Baicalin inhibits monosodium urate crystal‐induced pyroptosis in renal tubular epithelial cell line through Panx‐1/P2X7 pathways: Molecular docking, molecular dynamics, and in vitro experiments
di: Wanting Fu, et al.
Pubblicazione: (2024)

Multi‐Omics and Machine Learning‐Driven Discovery of ABCC8 ( SUR1 ) for Diabetes Mellitus: Integrating Molecular Insights on Nigella sativa Bioactives and Sulfonylurea
di: Mohd Adnan, et al.
Pubblicazione: (2026)

Combination of Diosmetin With Chrysin Against Hepatocellular Carcinoma Through Inhibiting PI3K/AKT/mTOR/NF‐кB Signaling Pathway: TCGA Analysis, Molecular Docking, Molecular Dynamics, In Vitro Experiment
di: Xiang Yu, et al.
Pubblicazione: (2024)

Molecular Mechanisms and Efficacy of Tislelizumab, a PD ‐1 Inhibitor Developed in China, in Non‐Small Cell Lung Cancer
di: Yihao Liu, et al.
Pubblicazione: (2026)

Exploring the Effect of Gomisin A on Non‐Small Cell Lung Cancer With Network Pharmacology, Molecular Docking, In Vitro and In Vivo Assays
di: Mei Liu, et al.
Pubblicazione: (2024)

Advances in the Molecular Mechanism of Kappa Opioid Receptors Signaling and the Important Sampling Methods to Probe the Activation Landscape of GPCRs
di: Mingqiong Tong, et al.
Pubblicazione: (2025)

Novel Donepezil–Chalcone Hybrids as Potential Multifunctional Anti‐Alzheimer’s Disease Agents: Design, Synthesis, Computational Simulation, and In Vitro/In Vivo Biological Evaluation
di: Zhiqi Lin, et al.
Pubblicazione: (2026)

Network Pharmacology Integrated Experimental Validation Uncover Quercetin as the Key Ingredient of Hedyotis diffusa Anti‐BRCA
di: Queting Chen, et al.
Pubblicazione: (2025)

Machine Learning‐Based Discovery of a Novel Noncovalent MurA Inhibitor as an Antibacterial Agent
di: Qingxin Liu, et al.
Pubblicazione: (2025)

Design of Hybrid Bioactive Peptides Derived From Cecropin and Cathepsin for Therapeutic Application
di: Gabriele Santos Cepinho, et al.
Pubblicazione: (2025)

Targeting the Autophagy–Apoptosis Axis in Osteosarcoma: Therapeutic Potential of Biocompounds: A Review
di: Oznur Bayraktar Ekmekcigil, et al.
Pubblicazione: (2026)

The Immuno‐Metabolic Crosstalk in Lung Squamous Cell Carcinoma: Prognostic Insights and Therapeutic Clues
di: Haoyuan Xue, et al.
Pubblicazione: (2026)

Correction to “Targeting the Autophagy–Apoptosis Axis in Osteosarcoma: Therapeutic Potential of Biocompounds: A Review”
Pubblicazione: (2026)

Beyond ATP Synthase Inhibition: Chemical Diversification, Bioactivities, and Therapeutic Potential of Oligomycin A
di: Mohamed S. Nafie, et al.
Pubblicazione: (2025)

Unveiling the Therapeutic Potential of Paclitaxel Combinations Against Breast Carcinoma and Identification of In Vivo Biomarkers
di: Aamir Mehmood, et al.
Pubblicazione: (2024)

Reviewing the IDH1 Mutation‐Mediated Mechanism of Drug Resistance and Revisiting Its Overcoming Strategies
di: Yifan Wang, et al.
Pubblicazione: (2025)

Using Network Pharmacology and Transcriptome Sequencing to Investigate the Mechanism of Action of Luteolin and Quercetin in Treating Obesity
di: Ruoshuang Liu, et al.
Pubblicazione: (2025)

A recent update on huprine and its hybrids as a potential multifunctional agent for the treatment of Alzheimer's disease
di: Yash Pal Singh, et al.
Pubblicazione: (2024)

An AI ‐Guided Structure‐Based Strategy for the Discovery and Biological Validation of Natural Products Targeting the Vitamin D Receptor From YSQYP in Diabetic Kidney Disease
di: Xinze Liu, et al.
Pubblicazione: (2026)

Oridonin Alleviates Doxorubicin‐Induced Cardiotoxicity by Inhibiting p38 MAPK/MMP3 Signaling Pathway
di: Xingyuan Hou, et al.
Pubblicazione: (2025)

Multifaceted In Silico Screening Strategies Identifies Potent Inhibitors Facilitating Inhibition of ZNF726 Activity in Breast Cancer
di: Shreetama Bandyopadhayaya, et al.
Pubblicazione: (2025)

Integrative Experimental Paradigm of Oxadiazole–Schiff Base Hybrids: Pharmacophore‐Driven Docking Simulations and DFT Insights Toward Antidiabetic Therapeutic Discovery
di: Aisha Bibi, et al.
Pubblicazione: (2026)

Peimenine unleashes therapeutic promise in urothelial bladder cancer: inhibition of proliferation, induction of cell death and modulation of key pathways
di: Zhao Yang, et al.
Pubblicazione: (2024)

Integrative Multi‐Omics Analysis Identifies FTO as a Genetic and Epigenetic Link Between Metabolic Susceptibility and Staphylococcus aureus ‐Induced Airway Remodeling in Chronic Rhinosinusitis
di: Xinjie Qiao, et al.
Pubblicazione: (2026)